Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2026-02-21 @ 11:35 PM
Study NCT ID:
NCT03911102
Status:
COMPLETED
Last Update Posted:
2023-06-27
First Post:
2019-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines
Sponsor:
Revance Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-11
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-23
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-27
First Submit QC Date:
None
Study First Post Date:
2019-04-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-02
Results First Submit QC Date:
None
Results First Post Date:
2023-06-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-02-12
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-06-02
Last Update Post Date:
2023-06-27
Last Update Post Date Type:
ACTUAL